InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
76,284.58
(
-0.37%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

micanwait

Send PM Follow Ignore
Followers 6
Posts 718
Boards Moderated 0
Alias Born 06/22/2011

micanwait

Re: JJM760 post# 19383

Monday, 06/04/2012 4:40:23 PM

Monday, June 04, 2012 4:40:23 PM

Post# of 80490
I suspect that most oncologists will have the same opinion as Dr. Cortes --- the most likely best outcome will come from using the most likely best drug.

The health insurers may not like it, but the medical liability insurers may have a different point of view.

I still think that the possible loss of the huge Gleevec income stream is a huge incentive for Novartis to explore acquiring Ariad.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up